EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Refining the Bariatric Journey: A Proposed Neoadjuvant and Adjuvant Framework for GLP-1 Receptor Agonists Inspired by Oncology

Ke Song, Qian Zhang, Siyu Li, Qiang Du, Stephen Ka-Kei Ng, Yutong Chen, Yujie Pu, Jason Widjaja, HaiYang Chen, Yi Chen

Current Obesity Reports · 11.06.2026 · 15 (1)

DOI: 10.1007/s13679-026-00726-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Obesity Reports, online erschienen am 11.06.2026. Verfasst von Ke Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Bariatric Surgery, Neoadjuvant Therapy, Obesity, Morbid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, 1·3·5 Project for Disciplines of Excellence in Artificial Intelligence, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: Bariatric surgery is the most effective intervention for severe obesity, yet challenges such as perioperative risks in super-obesity and long-term weight regain persist. This narrative review proposes a novel multimodal framework for integrating GLP-1 receptor agonists (GLP-1 RAs) into surgical pathways. Drawing a conceptual analogy from oncologic "neoadjuvant" and "adjuvant" treatment models, we explore how pharmacotherapy can optimize surgical safety and reinforce long-term metabolic control. RECENT FINDINGS: Emerging clinical data from prospective trials demonstrate that a short-term "neoadjuvant" course of GLP-1 receptor agonists can significantly enhance early weight loss and dyslipidemia remission without compromising perioperative safety. Conversely, retrospective analyses suggest that while preoperative weight loss is achievable, it requires careful management to mitigate potential early metabolic adaptation and prevent the "ceiling effect" on postoperative outcomes. Regarding postoperative care, recent meta-analyses confirm that adjuvant pharmacotherapy effectively addresses weight regain and sustains metabolic improvements in suboptimal responders, supporting the implementation of a structured perioperative management ladder. Obesity management is shifting from a procedure-centric approach toward a chronic, multimodal disease model. The neoadjuvant/adjuvant paradigm encourages clinicians to leverage pharmacologic tools to enhance surgical efficacy ("downstaging" risk) and prevent disease recurrence. While primarily hypothesis-generating, this framework provides a structured foundation-including a proposed perioperative management ladder-for future randomized controlled trials to establish integrated, multidisciplinary clinical standards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsBariatric SurgeryNeoadjuvant TherapyObesity, MorbidHumansWeight Loss

Stichwörter der Autor:innen

Adjuvant therapyBariatric surgeryGLP-1 receptor agonistsNeoadjuvant therapyObesityObesity treatment modelPharmacotherapyPrecision Medicine

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • West China School of Medicine, Sichuan University, No.37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, 610041, China.
  • West China Centre of Excellence for Pancreatitis, and Laboratory of Metabolism and Aging, Frontiers Science Center for Disease-related Molecular Network, National Clinical Research Center for Geriatrics, West China Hosp…
  • Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University/West China School of Nursing, Sichuan Univ…
  • Division of Upper Gastrointestinal and Metabolic Surgery, Department of Surgery, Prince of Wales Hospital, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
  • Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China. drjwbs@yahoo.com.

Förderung

  • Natural Science Foundation of Sichuan Province
  • 1·3·5 Project for Disciplines of Excellence in Artificial Intelligence, West China Hospital, Sichuan University

Zitieren

APA

Song, K., Zhang, Q., Li, S., Du, Q., Ng, S. K., Chen, Y., Pu, Y., Widjaja, J., Chen, H., & Chen, Y. (2026). Refining the Bariatric Journey: A Proposed Neoadjuvant and Adjuvant Framework for GLP-1 Receptor Agonists Inspired by Oncology. Current Obesity Reports, 15(1). https://doi.org/10.1007/s13679-026-00726-3

Vancouver

Song K, Zhang Q, Li S, Du Q, Ng SK, Chen Y, et al. Refining the Bariatric Journey: A Proposed Neoadjuvant and Adjuvant Framework for GLP-1 Receptor Agonists Inspired by Oncology. Current Obesity Reports. 2026;15(1). doi:10.1007/s13679-026-00726-3

BibTeX
@article{Song2026,
  author = {Song, Ke and Zhang, Qian and Li, Siyu and Du, Qiang and Ng, Stephen Ka-Kei and Chen, Yutong and Pu, Yujie and Widjaja, Jason and Chen, HaiYang and Chen, Yi},
  title = {Refining the Bariatric Journey: A Proposed Neoadjuvant and Adjuvant Framework for GLP-1 Receptor Agonists Inspired by Oncology},
  journal = {Current Obesity Reports},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1007/s13679-026-00726-3}
}
Kostenlos starten →